These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2455592

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Combination nonviral cytokine gene therapy for head and neck cancer.
    Li D, Zeiders JW, Liu S, Guo M, Xu Y, Bishop JS, O'Malley BW.
    Laryngoscope; 2001 May; 111(5):815-20. PubMed ID: 11368072
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
    Ishii T, Marumo K.
    Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C, Rinaudo JA, Farrar K, Wells F, Korba BE.
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
    Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4556-64. PubMed ID: 17671142
    [Abstract] [Full Text] [Related]

  • 36. Time-dependent cytotoxic action of human recombinant alpha-interferon (Ro22-8181) in vitro and the sensitivity of various cultured leukemia and lymphoma cell lines to it.
    Shibata T, Shimada Y, Shimoyama M.
    Jpn J Clin Oncol; 1985 Mar 01; 15(1):67-75. PubMed ID: 3981816
    [Abstract] [Full Text] [Related]

  • 37. Constitutive production of lymphokines by cloned murine B-cell lymphomas--CH12 B lymphoma produces interleukin-4.
    O'Garra A, Barbis D, Harada N, Lee F, Howard M.
    J Mol Cell Immunol; 1989 Mar 01; 4(3):149-58; discussion 158-9. PubMed ID: 2788429
    [Abstract] [Full Text] [Related]

  • 38. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 39. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
    Sunkara PS, Bowlin TL, Rosenberger AL, Fleischmann WR.
    J Biol Response Mod; 1989 Apr 01; 8(2):170-9. PubMed ID: 2499664
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.